Ilynn Bulatao
United States Food and Drug Administration(US)Center for Drug Evaluation and Research(US)National Marine Sanctuary Foundation(US)
Publications by Year
Research Areas
Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Renal Transplantation Outcomes and Treatments, Prostate Cancer Treatment and Research, PARP inhibition in cancer therapy
Most-Cited Works
- → Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death Donors(2011)157 cited
- → Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries(2019)138 cited
- → Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors(2012)112 cited
- → Is a Mandatory Intensive Care Unit Stay Needed After Liver Transplantation? Feasibility of Fast-Tracking to the Surgical Ward After Liver Transplantation(2011)81 cited
- → Avoiding Stay in the Intensive Care Unit After Liver Transplantation: A Score to Assign Location of Care(2014)54 cited
- → Functional status predicts major complications and death after endovascular repair of abdominal aortic aneurysms(2017)45 cited